FABLE THERAPEUTICS Trademark

Trademark Overview


On Tuesday, November 12, 2024, a trademark application was filed for FABLE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the FABLE THERAPEUTICS trademark a serial number of 98849309. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, September 15, 2025. This trademark is owned by Fable Therapeutics, Inc.. The FABLE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; drug discovery services; pharmaceutical research and development services; providing online non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of biotechnology and pharmaceuticals; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of biotechnology and pharmaceuticals; providing online non-downloadable computer software for use in generating, analyzing, and accessing data via artificial intelligence and machine learning; software as a service (SAAS) services featuring software for use in generating, analyzing, and accessing data via artificial intelligence and machine learning; providing an online non-downloadable computer software platform for discovering proteins and drugs, forecasting potential ...
fable therapeutics

General Information


Serial Number98849309
Word MarkFABLE THERAPEUTICS
Filing DateTuesday, November 12, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, September 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2025

Trademark Statements


NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; drug discovery services; pharmaceutical research and development services; providing online non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of biotechnology and pharmaceuticals; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of biotechnology and pharmaceuticals; providing online non-downloadable computer software for use in generating, analyzing, and accessing data via artificial intelligence and machine learning; software as a service (SAAS) services featuring software for use in generating, analyzing, and accessing data via artificial intelligence and machine learning; providing an online non-downloadable computer software platform for discovering proteins and drugs, forecasting potential uses of proteins and drug compounds and generating insights from screening and analyzing molecules, featuring software using artificial intelligence and machine learning; providing temporary use of non-downloadable computer software for discovering proteins and drugs, forecasting potential uses of proteins and drug compounds and generating insights from screening and analyzing molecules, all using artificial intelligence and machine learning; software as a service (SAAS) services featuring software for discovering proteins and drugs, forecasting potential uses of proteins and drug compounds and generating insights from screening and analyzing molecules, all using artificial intelligence and machine learning; providing an online non-downloadable computer software platform for analyzing molecular data; providing temporary use of non-downloadable computer software for generating and analyzing molecular data for biotechnology and pharmaceutical companies; software as a service (SAAS) services featuring software for generating and analyzing molecular data for biotechnology and pharmaceutical companies; preclinical drug discovery and development services used for identifying, designing, and optimizing chemical and biological compounds; pharmaceutical evaluation and preclinical evaluation of biological and chemical series and biological and chemical compounds in drug discovery; pharmaceutical drug development and discovery services, namely, identifying, designing, optimizing, and developing biological and chemical series and biological and chemical compounds via software using artificial intelligence and machine learning; providing an online searchable database in the fields of proteins and pharmaceuticals for scientific research purposes, in particular, pharmaceutical research and development, scientific research and development of proteins and pharmaceutical preparations, scientific development of new uses for proteins and pharmaceutical compounds, and scientific technical research; scientific research and development for forecasting the use of molecules as diagnostics, prognostics, and drug compounds and developing new uses for pharmaceutical compounds; research and development in the field of drug discovery and development, diagnostics and prognostics; drug discovery services, namely, discovering novel molecules to develop into drug compounds; medical research and development in the field of biopharmaceuticals, diagnostics, prognostics, and protein engineering

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 12, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFable Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Tuesday, November 12, 2024NEW APPLICATION ENTERED
Tuesday, May 13, 2025NON-FINAL ACTION E-MAILED
Saturday, April 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 8, 2025ASSIGNED TO EXAMINER
Monday, August 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 13, 2025NON-FINAL ACTION WRITTEN
Tuesday, May 13, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 4, 2025APPROVED FOR PUB - PRINCIPAL REGISTER